Diagnostics & Healthcare News

Boston Scientific Corporation has received U.S. Food and Drug Administration approval of its fourth-generation Vercise Genus Deep Brain Stimulation (DBS) System. The portfolio, approved for conditional use in a magnetic resonance imaging (MRI) environment, consists of a family of Bluetooth-enabled, rechargeable and non-rechargeable, implantable pulse generators (IPGs) that power Cartesia Directional Leads, designed to provide…

STERIS plc (NYSE: STE) (“STERIS” or the “Company”) and Cantel Medical Corp (NYSE:CMD) (“Cantel”) today announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary.  Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers.  Under the terms of the agreement, STERIS will…

Enables Itamar to leverage Spry’s existing FDA-cleared technology to bring to market the first device for continuous remote patient monitoring (RPM) of sleep apnea Adds the capability to monitor the longer-term accumulated disease burden of sleep apnea to complement the single night diagnostics commonly used today, including the Company’s existing WatchPAT™ device Paves the way…

Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, subject to working capital and other customary closing adjustments. “Acquiring Biotheranostics enables us to jump-start our…

BioTelemetry, Inc., the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced that they have entered into a definitive merger agreement with Royal Philips (NYSE: PHG, AEX: PHIA). Royal Philips, a global leader in health technology, and BioTelemetry, Inc., a…

Olympus Corporation today announced that it has entered into an agreement to acquire Veran Medical Technologies, Inc. (VMT), a leading provider of advanced medical devices specializing in interventional pulmonology, for up to USD 340 million. The acquisition will be implemented through Olympus subsidiary Olympus Corporation of the Americas (OCA) and will be the latest in a…

Freudenberg Medical, member of the Freudenberg Group and a global developer and manufacturer of specialty components and finished devices for the medical device industry, has completed construction of a new medical manufacturing operation in Beverly, Massachusetts. Freudenberg Medical has established the facility as its new global headquarters and the location will manufacture medical devices and components in…

The National Sleep Foundation (NSF) named Itamar Medical Ltd. (NASDAQ and TASE: ITMR) winner of the 2020 SleepTech Award. The SleepTech Award recognizes the year’s most innovative efforts in advancing sleep technology. Itamar Medical is a technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of…

BioProtect ltd., a private company with a unique bioabsorbable polymer spacer balloon platform, announced the final closing of $25 million of its Series D equity financing from an unnamed strategic investor and Peregrine Ventures. Every year, more than 1.1 million men are diagnosed with prostate cancer worldwide and approximately 400,000 will undergo prostate radiotherapy. Historically prostate radiation…

Fitbit has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as Conformité Européenne (CE)marking in the European Union, for its electrocardiogram (ECG) app to assess heart rhythm for atrial fibrillation (AFib), a condition that affects more than 33.5 million people globally. The Fitbit ECG App, unveiled in Fitbit’s recent fall product launch, will…